Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources
Home/Rare Diseases/Cold Agglutinin Disease

Blood & Immune

Cold Agglutinin Disease (CAD) Clinical Trials and Treatments

Also called CAD, cold antibody hemolytic anemia, primary cold agglutinin disease

Cold agglutinin disease (CAD) is a rare autoimmune hemolytic anemia caused by pathogenic IgM autoantibodies that react in the cold and bind red blood cell surface antigens, usually the I antigen. These IgM-coated red blood cells switch on the classical complement pathway.

In plain words, cold agglutinin disease is a rare immune condition where antibodies stick to red blood cells when the body gets cold. These marked cells are then destroyed, mostly in the liver, which leads to a shortage of red blood cells called anemia.

Get an email when new Cold Agglutinin Disease trials open or the FDA decides. Get alerts

Cold Agglutinin Disease

Where treatments stand, from ClinicalTrials.gov and FDA labels

Also 1 study with no phase, like observational studies.

FDA review0

No decision pending. FDA calendar

FDA-approved medicines1

Enjaymo

Cold Agglutinin Disease has 1 FDA-approved medicine, 1 open or active clinical trial (1 recruiting), and no pending FDA decision.

Labels checked October 21, 2026. Corticosteroids and immune globulins count once each.Download the data

Latest for Cold Agglutinin Disease

See all trialsThe week in rare disease

Each date is the day a change was posted. Open an item to see where things stand now.

More about Cold Agglutinin Disease

This coats the cells with a complement protein called C3b, and immune cells, mainly in the liver, then remove them from the blood. That removal outside the blood vessels is the main cause of red cell loss in stable disease. In severe disease and flares, complement can also go on to burst red cells inside the blood vessels.

Keep reading about Cold Agglutinin Disease

Patients experience hemolytic anemia with symptoms and severity exacerbated by cold exposure; even minor cold contact triggers hemolytic episodes. The disease presents with jaundice from bilirubin release and with hemolytic anemia with reduced hemoglobin and elevated reticulocyte count. Some people also have dark red or cola-colored urine from hemoglobin released into the blood (15% in one series).

Acrocyanosis (blue discoloration of extremities) and Raynaud phenomenon occur from red cell agglutination in peripheral circulation reducing blood flow. Episodes of acute hemolysis triggered by cold exposure can be severe and life-threatening.

In primary CAD, a small abnormal group of B cells in the bone marrow makes the cold agglutinin, so it is now seen as a low-grade bone marrow disorder. Doctors call the similar illness that follows an infection or an aggressive lymphoma cold agglutinin syndrome. Diagnosis is confirmed by direct antiglobulin (Coombs) test showing complement (C3, C3d) without IgG deposition (complement-only pattern diagnostic of CAD).

What are the symptoms of Cold Agglutinin Disease?

These are common symptoms of Cold Agglutinin Disease, and how strong they are varies from person to person.

  • Hemolytic anemia and fatigue
  • Symptoms worsened by cold exposure
  • Jaundice and dark urine
  • Acute hemolytic episodes in cold weather
  • Acrocyanosis and Raynaud phenomenon
  • Autoimmune complications

Who gets Cold Agglutinin Disease?

Mostly affects older adults. In a Norwegian population study of 86 people, the median age when the disease began was 67, and women outnumbered men nearly 2 to 1. In that study 90% had an abnormal light chain pattern in the bone marrow and 76% had signs of a slow-growing lymphoma.

A similar illness called cold agglutinin syndrome can follow infections such as Mycoplasma pneumoniae or Epstein-Barr virus, or an aggressive lymphoma.

Next steps: find trials you might fitsee approved treatmentsget help payingget alerts

Which medicines are FDA-approved for Cold Agglutinin Disease?

There is currently 1 FDA-approved medication for Cold Agglutinin Disease.

sutimlimab-jome
Recordati Rare Diseases (acquired from Sanofi in November 2024)
Search

Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.

How to get help paying for Cold Agglutinin Disease treatment

Charity funds and drugmaker programs for Cold Agglutinin Disease, checked at the source.

Which insurance do you have? Pick one to see what fits. Tap it again to clear.
Your insurance
Charity funds
  • From a charity · The Assistance Fund
    Cold Agglutinin Disease (CAD) fund
    Waitlist

    Pays for: Copays, coinsurance, deductibles and other health-related expenses.

Status as each foundation showed it on November 17, 2026.
Drugmaker programs
Open a medicine for who qualifies, by insurance type.

Every program and fund for Cold Agglutinin Disease, by insurance →

Side effects people have reported to the FDA

Side effects people have reported to the FDA

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Diagnosis and genetic testing

How Cold Agglutinin Disease is diagnosed

Caused by IgM autoantibodies; secondary CAD follows infection or lymphoproliferative disease. No germline gene test.

Trusted Cold Agglutinin Disease resources

Reputable organizations and medical references for learning more about Cold Agglutinin Disease, including disease registries, foundation resources, and clinical guidelines.

Active clinical trials for Cold Agglutinin Disease

Use this Cold Agglutinin Disease clinical trial finder to see the 1 study recruiting patients in the United States and worldwide, with eligibility criteria in plain English. It does not test a treatment; it follows patients over time. Every trial comes from ClinicalTrials.gov.

Jump to the trial list, the site map or the pipeline timeline.

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

1 active trial worldwide
Filter:
Sort:
RecruitingObservational study, no treatment givenHasn't posted an update in over a yearNCT05931718

Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia

Intervention: cytokine essays, NGS, Fecal microbiome, Erythropoietin, Luspatercept, Thrombopoietin Receptor Agonist, G-CSF

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

The goal of this observational study is to characterize the diagnostic and therapeutic management of autoimmune cytopenias including autoimmune hemolytic anemia, immune thrombocytopenia, and chronic idiopathic/autoimmune neutropenia.

The main aims to answer are:

Ages 18 Years+1 location
Started Jun 2019Updated 2 years agoEst. Sep 2030 (~3y 10m)
Find Cold Agglutinin Disease trials near you, ranked by distance →
Active trial locations1 city
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.

Trial Pipeline

Jan 2021 to Nov 2031
2021
2023
2025
2027
2029
2031
now
Observational
RecruitingNot yet recruitingDelayed startTodayHover a bar for trial details

Read more about Cold Agglutinin Disease trials

Need help understanding these trials?
Answers with sources, in plain English
Start withor ask
Run a Cold Agglutinin Disease foundation or patient group?
You can put this live trial list on your own website. It updates itself, and it's free.
Get the embed code →

Data from ClinicalTrials.gov, U.S. National Library of Medicine.
Always talk to your doctor before considering a clinical trial.

Cold Agglutinin Disease patient communities

Facebook groups, Reddit communities and YouTube channels where Cold Agglutinin Disease patients, caregivers and advocacy groups talk.

Cold Agglutinin Disease news and guides

Trial Friend articles about Cold Agglutinin Disease, newest first

Companies developing Cold Agglutinin Disease treatments

Drugmakers that list Cold Agglutinin Disease in their rare disease portfolio, 4 in all.

Questions people ask about Cold Agglutinin Disease